Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-04 4:31 pm Purchase | 2025-07-28 | 13G | Ikena Oncology, Inc. IKNA | Deep Track Capital LP | 878,516 7.860% | 878,516 (New Position) | Filing History |
| 2025-08-04 4:29 pm Sale | 2025-07-28 | 13G | Ikena Oncology, Inc. IKNA | Deep Track Capital LP | 0 0.000% | -209,626 (Position Closed) | Filing History |
| 2025-07-28 5:00 pm Purchase | 2025-07-21 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Deep Track Capital LP | 2,352,960 5.600% | 2,352,960 (New Position) | Filing History |
| 2025-06-20 4:23 pm Purchase | 2025-04-28 | 13G | Jade Biosciences, Inc. JBIO | Deep Track Capital LP | 2,784,648 8.640% | 2,784,648 (New Position) | Filing History |
| 2025-05-16 4:42 pm Purchase | 2025-05-09 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital LP | 7,000,000 5.570% | 1,000,000 (+16.67%) | Filing History |
| 2025-05-15 08:47 am Sale | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital LP | 5,576,558 6.390% | -523,442 (-8.58%) | Filing History |
| 2025-05-15 08:46 am Sale | 2025-03-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Deep Track Capital LP | 3,442,833 5.040% | -557,167 (-13.93%) | Filing History |
| 2025-05-15 08:45 am Purchase | 2025-03-31 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital LP | 15,458,138 9.650% | 6,227,369 (+67.46%) | Filing History |
| 2025-05-15 08:44 am Purchase | 2025-03-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 5,500,000 7.210% | 1,375,000 (+33.33%) | Filing History |
| 2025-05-15 08:43 am Sale | 2025-03-31 | 13G | Mind Medicine (MindMed) Inc. MNMD | Deep Track Capital LP | 6,500,000 8.190% | -166,667 (-2.50%) | Filing History |
| 2025-05-15 08:43 am Sale | 2025-03-31 | 13G | Invivyd, Inc. IVVD | Deep Track Capital LP | 9,722,254 8.100% | -1,231,683 (-11.24%) | Filing History |
| 2025-05-15 08:42 am Purchase | 2025-03-31 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital LP | 12,300,000 7.150% | 3,300,000 (+36.67%) | Filing History |
| 2025-05-15 08:41 am Sale | 2025-03-31 | 13G | Guardant Health, Inc. GH | Deep Track Capital LP | 5,443,721 4.410% | -1,136,536 (-17.27%) | Filing History |
| 2025-05-15 08:39 am Purchase | 2025-03-31 | 13G | 89bio, Inc. ETNB | Deep Track Capital LP | 13,816,333 9.180% | 7,338,384 (+113.28%) | Filing History |
| 2025-05-15 08:38 am Unchanged | 2025-03-31 | 13G | Context Therapeutics Inc. CNTX | Deep Track Capital LP | 7,419,355 8.270% | 0 (Unchanged) | Filing History |
| 2025-05-15 08:37 am Sale | 2025-03-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital LP | 2,821,171 5.670% | -509,065 (-15.29%) | Filing History |
| 2025-05-15 08:36 am Purchase | 2025-03-31 | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 7,232,701 8.020% | 4,721,965 (+188.07%) | Filing History |
| 2025-05-13 4:32 pm Purchase | 2025-05-06 | 13G | Oruka Therapeutics, Inc. ORKA | Deep Track Capital LP | 1,896,780 5.070% | 1,896,780 (New Position) | Filing History |
| 2025-04-10 4:14 pm Purchase | 2025-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX | Deep Track Capital LP | 3,250,000 5.290% | 3,250,000 (New Position) | Filing History |
| 2025-03-26 4:09 pm Purchase | 2025-03-19 | 13G | Immunovant, Inc. IMVT | Deep Track Capital LP | 9,500,000 5.590% | 8,500,000 (+850.00%) | Filing History |